Capturing adaptive immunity against SARS-CoV-2 in patients with cancer

被引：0
|
作者：
Hendrik Luxenburger
Robert Thimme
机构：
[1] Freiburg University Medical Center,Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases)
[2] Faculty of Medicine,IMM
[3] University of Freiburg,PACT, Faculty of Medicine
[4] University of Freiburg,undefined
来源：
Nature Cancer | 2021年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer is associated with higher risk of severe COVID-19 outcomes. Two studies prospectively analyze the immunological and clinical characteristics of a large cohort of patients with cancer following SARS-CoV-2 infection or vaccination, providing important clinical insights to improve the management of such vulnerable patients.
引用
收藏
页码：1298 / 1300
页数：2
相关论文
共 50 条
  • [31] Current understanding of T cell immunity against SARS-CoV-2
    Xiuyuan Lu
    Sho Yamasaki
    Inflammation and Regeneration, 42
  • [32] Current understanding of T cell immunity against SARS-CoV-2
    Lu, Xiuyuan
    Yamasaki, Sho
    INFLAMMATION AND REGENERATION, 2022, 42 (01)
  • [33] Meditation: The natural immunity booster ploy against SARS-CoV-2
    Sharma, Vinay
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2022, 11 : 1 - 6
  • [34] Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
    Hagit Achdout
    Einat. B. Vitner
    Boaz Politi
    Sharon Melamed
    Yfat Yahalom-Ronen
    Hadas Tamir
    Noam Erez
    Roy Avraham
    Shay Weiss
    Lilach Cherry
    Erez Bar-Haim
    Efi Makdasi
    David Gur
    Moshe Aftalion
    Theodor Chitlaru
    Yaron Vagima
    Nir Paran
    Tomer Israely
    Nature Communications, 12
  • [35] Enhanced immunity against SARS-CoV-2 in returning Chinese individuals
    Yuan, Runyu
    Chen, Huimin
    Yi, Lina
    Li, Xinxin
    Hu, Ximing
    Li, Xing
    Zhang, Huan
    Zhou, Pingping
    Liang, Chumin
    Lin, Huifang
    Zeng, Lilian
    Zhuang, Xue
    Ruan, Qianqian
    Chen, Yueling
    Deng, Yingyin
    Liu, Zhe
    Lu, Jing
    Xiao, Jianpeng
    Chen, Liang
    Xiao, Xincai
    Li, Jing
    Li, Baisheng
    Li, Yan
    He, Jianfeng
    Sun, Jiufeng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [36] Innate immunity: the first line of defense against SARS-CoV-2
    Michael S. Diamond
    Thirumala-Devi Kanneganti
    Nature Immunology, 2022, 23 : 165 - 176
  • [37] Cellular immunity against SARS-CoV-2 depends on the serological status
    Pighi, Laura
    Henry, Brandon M.
    De Nitto, Simone
    Salvagno, Gian Luca
    Lippi, Giuseppe
    JOURNAL OF INFECTION, 2023, 87 (01) : 57 - 58
  • [38] Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
    Achdout, Hagit
    Vitner, Einat. B.
    Politi, Boaz
    Melamed, Sharon
    Yahalom-Ronen, Yfat
    Tamir, Hadas
    Erez, Noam
    Avraham, Roy
    Weiss, Shay
    Cherry, Lilach
    Bar-Haim, Erez
    Makdasi, Efi
    Gur, David
    Aftalion, Moshe
    Chitlaru, Theodor
    Vagima, Yaron
    Paran, Nir
    Israely, Tomer
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [39] Eye drop vaccination gives immunity against SARS-CoV-2
    Schrage, Norbert
    Blomet, Joel
    Holzer, Frank
    Tromme, Adrien
    Ectors, Fabien
    Desmecht, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [40] Humoral and cellular immunity against diverse SARS-CoV-2 variants
    Chen, Changxu
    Wang, Xin
    Zhang, Zeli
    JOURNAL OF GENETICS AND GENOMICS, 2023, 50 (12) : 934 - 947
12345